title: The good, the bad and the ugly of the new treatments for hepatitis C virus.
authors.affiliation: Liver Research Unit, Medica Sur Clinic & Foundation. Mexico City, Mexico.
authors.forename: Karen V
authors.initials: KV
authors.lastname: Silva-Vidal
authors.affiliation: Liver Research Unit, Medica Sur Clinic & Foundation. Mexico City, Mexico.
authors.forename: Nahum
authors.initials: N
authors.lastname: Méndez-Sánchez
mesh_terms: D016527:Drug Costs / Q000706:statistics & numerical data*; D016174:Hepacivirus / Q000187:drug effects*; D019698:Hepatitis C, Chronic; D006575:Heterocyclic Compounds, 3-Ring / Q000191:economics*; D006801:Humans; D012254:Ribavirin / Q000191:economics*; D013449:Sulfonamides / Q000191:economics*; D014542:Uridine Monophosphate / Q000031:analogs & derivatives*
chemical_list: D006575:Heterocyclic Compounds, 3-Ring; D013449:Sulfonamides; D012254:Ribavirin; D014542:Uridine Monophosphate